Which hedge funds own STRO? SUTRO BIOPHARMA INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
7 of the hedge funds tracked by WhaleCreep disclosed a position in STRO (SUTRO BIOPHARMA INC) in their Q2 2026 13F filings, worth $48.3m in total. The largest holder by portfolio weight is Woodline Partners at 0.0% of its book. 1 manager opened a new position this quarter: D. E. Shaw & Co. 2 exited: Brevan Howard Capital Management, RA Capital Management.
7tracked managers holding
1opened this quarter
2exited this quarter
Which hedge funds hold STRO? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Woodline Partners | Q2 2026 | 0.0% | $15.2m | 458,029 | 0% | held |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $7.9m | 237,827 | -66% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $12.2m | 365,972 | 74% | added |
| Marshall Wace | Q2 2026 | 0.0% | $5.8m | 175,246 | -21% | reduced |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $2.9m | 86,324 | -12% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $3.4m | 101,965 | -13% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $1.0m | 30,128 | – | new |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Brevan Howard Capital Management | 0.0% | $468.1k |
| RA Capital Management | 0.6% | $17.8m |
How has hedge fund ownership of STRO changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 7 | $48.3m |
| Q1 2026 | 8 | $63.1m |
| Q4 2025 | 2 | $3.5m |
| Q3 2025 | 2 | $6.9m |
| Q2 2025 | 2 | $5.3m |
| Q1 2025 | 3 | $8.3m |
| Q4 2024 | 4 | $19.7m |
| Q3 2024 | 4 | $50.7m |
| Q2 2024 | 4 | $46.9m |
| Q1 2024 | 4 | $60.4m |
| Q4 2023 | 6 | $63.0m |
| Q3 2023 | 7 | $57.3m |
| Q2 2023 | 8 | $79.7m |
| Q1 2023 | 7 | $58.3m |
| Q4 2022 | 8 | $104.9m |
| Q3 2022 | 9 | $82.3m |
Counts every tracked manager that disclosed STRO in that quarter's filing, including managers that have since stopped filing.